Urinary diversion and morbidity after radical cystectomy for bladder cancer.

Cancer
John L GoreUrologic Diseases in America Project

Abstract

The rate of continent urinary diversion after radical cystectomy for bladder cancer varies by patient and provider characteristics. Demonstration of equivalent complication rates, independent of diversion type, may decrease provider reluctance to perform continent reconstructions. The authors sought to determine whether continent reconstructions confer increased complication rates after radical cystectomy. From the Nationwide Inpatient Sample, the authors used International Classification of Disease (ICD-9) codes to identify subjects who underwent radical cystectomy for bladder cancer during 2001-2005. They determined acute postoperative medical and surgical complications from ICD-9 codes and compared complication rates by reconstruction type using the nearest neighbor propensity score matching method and multivariate logistic regression models. Adjusting for case-mix differences between reconstructive groups, continent diversions conferred a lower risk of medical, surgical, and disposition-related complications that was statistically significant for bowel (3.1% lower risk; 95% confidence interval [95% CI], -6.8% to -0.1%), urinary (1.2% lower risk; 95% CI, -2.3%, to -0.4%), and other surgical complications (3.0% lower risk; 95...Continue Reading

References

Feb 1, 1992·British Journal of Urology·M C BensonC A Olsson
Jul 1, 1994·Medical Care·L I IezzoniG A Coffman
Feb 7, 1998·Medical Care·A ElixhauserR M Coffey
Apr 12, 2002·The New England Journal of Medicine·John D BirkmeyerDavid E Wennberg
Sep 8, 2005·The Journal of Urology·Brent K HollenbeckJohn T Wei
Jul 11, 2006·Cancer·John L GoreUNKNOWN Urologic Diseases in America Project
Dec 13, 2006·The Journal of Urology·Badrinath R Konety, Veerasathpurush Allareddy
Jan 18, 2007·JAMA : the Journal of the American Medical Association·Ralph B D'Agostino, Ralph B D'Agostino
Feb 22, 2008·The Journal of Urology·William T LowranceMichael S Cookson
Nov 21, 2008·World Journal of Urology·John L GoreUNKNOWN Urologic Diseases in America Project

❮ Previous
Next ❯

Citations

Nov 26, 2010·World Journal of Urology·John L GoreUNKNOWN Urologic Diseases in America Project
Mar 8, 2012·World Journal of Urology·In Gab JeongChoung-Soo Kim
Feb 12, 2011·Current Opinion in Oncology·Todd M MorganPeter E Clark
Jun 19, 2013·Expert Review of Anticancer Therapy·John L Gore, Scott M Gilbert
Mar 19, 2013·The Journal of Urology·Scott M GilbertUNKNOWN Urologic Diseases in America Project
Oct 23, 2012·The Journal of Urology·Todd M MorganDavid F Penson
Nov 20, 2012·The Journal of Urology·Michael H JohnsonPeter A Humphrey
Sep 27, 2012·The Journal of Urology·Jonathan L SilbersteinJaspreet S Sandhu
Dec 21, 2010·The Journal of Urology·Mark S ShimkoIgor Frank
Sep 16, 2011·BJU International·Richard LeeDouglas S Scherr
Apr 20, 2011·BJU International·Richard LeeDouglas S Scherr
Jul 2, 2011·BJU International·Rolf GillitzerChristian Hampel
Aug 3, 2013·International Journal of Urology : Official Journal of the Japanese Urological Association·Florian RoghmannJüri Palisaar
Apr 9, 2016·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Lauren N MoomjianAdam P Klausner
Aug 4, 2015·Clinical Genitourinary Cancer·Rutveej PatelMichael Lasser
Apr 4, 2015·Hematology/oncology Clinics of North America·Mark A PrestonAdam S Kibel
Jul 28, 2016·Clinical Genitourinary Cancer·Michelle L McDonaldA Karim Kader
Nov 3, 2011·Nature Reviews. Urology·Richard E HautmannOliver Hautmann
Oct 25, 2017·BJU International·Matthew MossanenSteven L Chang
Oct 1, 2019·Therapeutic Advances in Urology·Jacob TaylorMarc A Bjurlin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.